Vertigo
1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Otolith LabsDC - Washington
3 programsOtobandN/A1 trial
Otoband ExperimentalN/A1 trial
Transcranial vibrating systemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
EisaiMerislon
Otolith LabsOtoband Experimental
Otolith LabsOtoband
Otolith LabsTranscranial vibrating system
Clinical Trials (4)
A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation
Start: May 20070
Phase 4Withdrawn
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
Start: Feb 2023Est. completion: Dec 2023
N/ACompleted
Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting
Start: Apr 2021Est. completion: Nov 2022
N/ACompleted
Transcranial Vibrating System for Improving Vestibular Physical Therapy
Start: Jan 2019Est. completion: Apr 2019
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space